Prot #BTCRC GYN15-013: Phase II Study of Pembrolizumab in Combination with Carboplatin and Paclitaxel for Advanced or Recurrent Endometrial Adenocarcinoma

Project: Research project

Project Details

StatusActive
Effective start/end date8/17/17 → 8/17/23

Funding

  • Hoosier Cancer Research Network, Inc. (Prot #BTCRC GYN15-013)
  • Merck Sharp & Dohme Corporation (Prot #BTCRC GYN15-013)